Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (483) Arrow Down
Filter Results: (483) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (120,054)
    • Faculty Publications  (483)

    Show Results For

    • All HBS Web  (120,054)
      • Faculty Publications  (483)

      Lerner, JoshRemove Lerner, Josh →

      ← Page 24 of 483 Results →
      • January 1994 (Revised November 1997)
      • Case

      Aberlyn Capital Management: July 1993

      By: Josh Lerner and Peter Tufano
      Aberlyn Capital Management, a venture leasing firm specializing in providing capital to biotechnology firms, proposes to introduce a new product. Aberlyn will base a lease on an intangible product: the patent of a biotechnology firm. This poses a series of short and... View Details
      Keywords: Financing and Loans; Valuation; Product Launch; Problems and Challenges; Patents; Financial Instruments; Financial Services Industry; Biotechnology Industry
      Citation
      Educators
      Purchase
      Related
      Lerner, Josh, and Peter Tufano. "Aberlyn Capital Management: July 1993." Harvard Business School Case 294-083, January 1994. (Revised November 1997.)
      • January 1994 (Revised July 1998)
      • Case

      Repligen Corporation: January 1992

      By: Josh Lerner and David Kane
      Sandford Smith, CEO of Repligen, faces the breakdown of negotiations about a proposed joint venture with a large pharmaceutical firm. He must decide whether to proceed using his firm's internal resources or whether to seek to revise the proposed collaboration. If the... View Details
      Keywords: Joint Ventures; Decisions; Contracts; Agreements and Arrangements; Value
      Citation
      Educators
      Purchase
      Related
      Lerner, Josh, and David Kane. "Repligen Corporation: January 1992." Harvard Business School Case 294-082, January 1994. (Revised July 1998.)
      • January 1994 (Revised November 2001)
      • Background Note

      Note on the Venture Leasing Industry, A

      By: Josh Lerner
      Provides an overview of venture leasing, an innovative financing mechanism that resembles both venture equity investments and bank lending. View Details
      Keywords: Finance
      Citation
      Educators
      Purchase
      Related
      Lerner, Josh. "Note on the Venture Leasing Industry, A." Harvard Business School Background Note 294-069, January 1994. (Revised November 2001.)
      • January 1994 (Revised April 1995)
      • Case

      EMC Corporation: Response to Shareholder Litigation (A)

      By: Josh Lerner
      EMC Corp. is the target of a shareholder class-action lawsuit for the second time. CEO, Richard Egan, must decide whether to settle the case, as is done in 96% of such cases and as EMC itself did previously, or fight the action. View Details
      Keywords: Decision Choices and Conditions; Lawsuits and Litigation; Going Public; Management Teams; Business and Shareholder Relations; Technology Industry; United States
      Citation
      Educators
      Purchase
      Related
      Lerner, Josh. "EMC Corporation: Response to Shareholder Litigation (A)." Harvard Business School Case 294-070, January 1994. (Revised April 1995.)
      • January 1994 (Revised April 1994)
      • Case

      EMC Corporation: Response to Shareholder Litigation (B)

      By: Josh Lerner
      Reports EMC's decision concerning the second shareholder class-action suit and its implications. Legislative efforts to reform securities litigation are also discussed. View Details
      Keywords: Decisions; Lawsuits and Litigation; Going Public; Policy; Management Teams; Business and Shareholder Relations; Technology Industry; United States
      Citation
      Educators
      Purchase
      Related
      Lerner, Josh. "EMC Corporation: Response to Shareholder Litigation (B)." Harvard Business School Case 294-071, January 1994. (Revised April 1994.)
      • April 1993 (Revised October 1995)
      • Case

      ALZA and Bio-Electro Systems (A): Technological and Financial Innovation

      By: Josh Lerner and Peter Tufano
      To develop the next generation of risky products, ALZA, a mature and profitable biotechnology firm specializing in drug delivery systems, must raise $40 million. Organizational constraints and competitive concerns demand that the work be done inside the firm. However,... View Details
      Keywords: Risk and Uncertainty; Technological Innovation; Business Subsidiaries; Decision Choices and Conditions; Corporate Finance; Biotechnology Industry; Medical Devices and Supplies Industry
      Citation
      Educators
      Purchase
      Related
      Lerner, Josh, and Peter Tufano. "ALZA and Bio-Electro Systems (A): Technological and Financial Innovation." Harvard Business School Case 293-124, April 1993. (Revised October 1995.)
      • April 1993 (Revised February 1996)
      • Supplement

      ALZA and Bio-Electro Systems (B1): Rights Offering Strategy

      By: Josh Lerner and Peter Tufano
      Supplements the (A) case. Describes the CEO's decision. View Details
      Keywords: Strategy; Intellectual Property
      Citation
      Purchase
      Related
      Lerner, Josh, and Peter Tufano. "ALZA and Bio-Electro Systems (B1): Rights Offering Strategy." Harvard Business School Supplement 293-125, April 1993. (Revised February 1996.)
      • April 1993 (Revised February 1996)
      • Supplement

      ALZA and Bio-Electro Systems (B2): The Rights Offering

      By: Josh Lerner and Peter Tufano
      Supplements the (A) case. Describes the implementation of the CEO's decision. View Details
      Keywords: Intellectual Property
      Citation
      Purchase
      Related
      Lerner, Josh, and Peter Tufano. "ALZA and Bio-Electro Systems (B2): The Rights Offering." Harvard Business School Supplement 293-126, April 1993. (Revised February 1996.)
      • April 1993 (Revised February 1996)
      • Supplement

      ALZA and Bio-Electro Systems (C): 1988-92

      By: Josh Lerner and Peter Tufano
      Supplements the (A) case. Describes the aftermarket performance of the units. View Details
      Keywords: Performance
      Citation
      Purchase
      Related
      Lerner, Josh, and Peter Tufano. "ALZA and Bio-Electro Systems (C): 1988-92." Harvard Business School Supplement 293-127, April 1993. (Revised February 1996.)
      • March 1993 (Revised May 1998)
      • Teaching Note

      ImmuLogic Pharmaceutical Corporation (Series) TN

      By: Josh Lerner
      Teaching Note for (9-293-066--071) and (9-293-087). View Details
      Keywords: Pharmaceutical Industry
      Citation
      Purchase
      Related
      Lerner, Josh. "ImmuLogic Pharmaceutical Corporation (Series) TN." Harvard Business School Teaching Note 293-118, March 1993. (Revised May 1998.)
      • 1993
      • Article

      Innovation and the Structure of High-Technology Industries

      By: Josh Lerner
      Keywords: Innovation and Invention; Information Technology; Business Ventures
      Citation
      Find at Harvard
      Related
      Lerner, Josh. "Innovation and the Structure of High-Technology Industries." Research on Technological Innovation, Management and Policy 5 (1993): 89–107.
      • December 1992 (Revised September 1996)
      • Case

      ImmuLogic Pharmaceutical Corporation (Abridged)

      By: Josh Lerner
      ImmuLogic Pharmaceutical Corp., a development-stage biotechnology company, is considering making an initial offering of common stock. The rationales for and problems of high-technology start-ups are explored. The challenges posed by "windows" for public offerings are... View Details
      Keywords: Decisions; Initial Public Offering; Entrepreneurship; Going Public; Business Startups; Biotechnology Industry; Pharmaceutical Industry; United States
      Citation
      Educators
      Purchase
      Related
      Lerner, Josh. "ImmuLogic Pharmaceutical Corporation (Abridged)." Harvard Business School Case 293-087, December 1992. (Revised September 1996.)
      • October 1992 (Revised November 1997)
      • Case

      ImmuLogic Pharmaceutical Corporation (A): March 1991

      By: Josh Lerner
      ImmuLogic Pharmaceutical Corp., a development-stage biotechnology company, is considering making an initial offering of common stock. The diverse perspectives of the entrepreneur, venture capitalist, investment banker, and institutional investor are explored. Problems... View Details
      Keywords: Decisions; Entrepreneurship; Venture Capital; Banks and Banking; Initial Public Offering; Going Public; Perspective; Valuation; Biotechnology Industry; Pharmaceutical Industry
      Citation
      Educators
      Purchase
      Related
      Lerner, Josh. "ImmuLogic Pharmaceutical Corporation (A): March 1991." Harvard Business School Case 293-066, October 1992. (Revised November 1997.)
      • October 1992 (Revised March 1993)
      • Supplement

      ImmuLogic Pharmaceutical Corporation (B1): Malcolm Gefter

      By: Josh Lerner
      Supplements the (A) case. View Details
      Keywords: Pharmaceutical Industry
      Citation
      Purchase
      Related
      Lerner, Josh. "ImmuLogic Pharmaceutical Corporation (B1): Malcolm Gefter." Harvard Business School Supplement 293-067, October 1992. (Revised March 1993.)
      • October 1992 (Revised April 1993)
      • Supplement

      ImmuLogic Pharmaceutical Corporation (B2): Henry McCance

      By: Josh Lerner
      Supplements the (A) case. View Details
      Keywords: Pharmaceutical Industry
      Citation
      Purchase
      Related
      Lerner, Josh. "ImmuLogic Pharmaceutical Corporation (B2): Henry McCance." Harvard Business School Supplement 293-068, October 1992. (Revised April 1993.)
      • October 1992 (Revised March 1993)
      • Supplement

      ImmuLogic Pharmaceutical Corporation (B3): Katherine Kirk

      By: Josh Lerner
      Supplements the (A) case. View Details
      Keywords: Pharmaceutical Industry
      Citation
      Purchase
      Related
      Lerner, Josh. "ImmuLogic Pharmaceutical Corporation (B3): Katherine Kirk." Harvard Business School Supplement 293-069, October 1992. (Revised March 1993.)
      • October 1992 (Revised April 1993)
      • Supplement

      ImmuLogic Pharmaceutical Corporation (B4): Phillip Gross

      By: Josh Lerner
      Supplements the (A) case. View Details
      Keywords: Pharmaceutical Industry
      Citation
      Purchase
      Related
      Lerner, Josh. "ImmuLogic Pharmaceutical Corporation (B4): Phillip Gross." Harvard Business School Supplement 293-070, October 1992. (Revised April 1993.)
      • October 1992 (Revised March 1993)
      • Supplement

      ImmuLogic Pharmaceutical Corporation (C): April 1991

      By: Josh Lerner
      Supplements the (A) case. View Details
      Keywords: Pharmaceutical Industry
      Citation
      Purchase
      Related
      Lerner, Josh. "ImmuLogic Pharmaceutical Corporation (C): April 1991." Harvard Business School Supplement 293-071, October 1992. (Revised March 1993.)
      • Teaching Interest

      Owner/President Management Progam (Executive Education)

      By: Josh Lerner
      As business owners and entrepreneurs prepare to take their companies to the next level in a highly competitive global arena, they must be fully equipped to master a range of skills—from strategy development to financial management to team... View Details
      • Teaching Interest

      Private Equity and Venture Capital (Executive Education)

      By: Josh Lerner

      As equity markets appear to strengthen, interest rates remain low, and asset values look attractive, private equity firms are uniquely positioned to pursue new opportunities. This View Details

      • ←
      • 24
      • 25
      • →
      ǁ
      Campus Map
      Harvard Business School
      Soldiers Field
      Boston, MA 02163
      →Map & Directions
      →More Contact Information
      • Make a Gift
      • Site Map
      • Jobs
      • Harvard University
      • Trademarks
      • Policies
      • Accessibility
      • Digital Accessibility
      Copyright © President & Fellows of Harvard College.